Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ATP150 + ATP152 + VSV-GP154 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ATP150 | ATP-150|ATP 150 | Limited information is currently available on ATP150, a putative therapeutic protein vaccine (May 2023). | ||
ATP152 | ATP-152|ATP 152 | Limited information is currently available on ATP152, a putative therapeutic protein vaccine (May 2023). | ||
VSV-GP154 | VSV GP154|VSVGP154 | Limited information is currently available on VSV-GP154, a putative viral vector-based therapeutic (May 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05846516 | Phase I | ATP150 + ATP152 + VSV-GP154 ATP150 + ATP152 + Ezabenlimab + VSV-GP154 | A Study to Evaluate ATP150/ATP152, VSV-GP154 and Ezabenlimab in Patients With KRAS G12D/G12V Mutated PDAC (KISIMA-02) | Recruiting | USA | CHE | 0 |